Image

Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients

Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Invasive filamentous fungal infections (aspergillosis, scedosporiosis, mucormycosis, fusarium wilt) are common and serious in immunocompromised subjects and particularly organ transplant patients. There is little recent data in heart transplantation, particularly on the incidence and risk factors of fungal infections. . It is therefore important to have recent data on incidence, risk and prognostic factors in order to improve the management of this severe complication.

Eligibility

Inclusion Criteria:

  • Adult patient ≥18 years old
  • Heart transplant
  • Invasive fungal infection with filamentous fungi during the period from January 1, 2008 to December 31, 2022
  • Proven or probable infection with filamentous fungi according to EORTC/MSGERC criteria (20):
    • Invasive aspergillosis
    • Mucormycosis
    • Fusarium wilt
    • Scedosporiosis
    • Other filamentous fungus infection
  • Subject who has not expressed, after information, his opposition to the reuse of his

    data for the purposes of this research.

Exclusion Criteria:

  • Patient having expressed his opposition to participating in the study
  • Patient not having a liver transplant
  • Subject under guardianship, curatorship or safeguard of justice.

Study details
    Invasive Fungal Infections

NCT06498310

University Hospital, Strasbourg, France

23 August 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.